REFERENCES
1. WHO. Cervical cancer. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer [accessed 27 Jul 2026].
2. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105:107-8.
3. Santía MC, Meschini T, Hsu HC, et al. Current updates on surgical management of patients with early-stage cervical cancer. Cancers. 2025;17:2259.
4. Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145:129-35.
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical cancer, Version 2.2026. Plymouth Meeting, PA: National Comprehensive Cancer Network, Inc.; 2026. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426 [accessed 27 Jul 2026].
6. Ramirez PT, Robledo KP, Frumovitz M, et al. LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer. J Clin Oncol. 2024;42:2741-6.
7. Abu-Rustum NR, Yashar CM, Bean S, et al. NCCN guidelines insights: cervical cancer, version 1.2020. J Natl Compr Canc Netw. 2020;18:660-6.
8. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84:145-9.
9. Schmeler KM, Pareja R, Lopez Blanco A, et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021;31:1317-25.
10. Carneiro VCG, Batista TP, Andrade MR, et al. Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER). Int J Gynecol Cancer. 2023;33:498-503.
11. Plante M, Kwon JS, Ferguson S, et al. Simple versus radical hysterectomy in women with low-risk cervical cancer. N Engl J Med. 2024;390:819-29.
12. Ferguson SE, Brotto LA, Kwon J, et al. Sexual health and quality of life in patients with low-risk early-stage cervical cancer: results from GCIG/CCTG CX.5/SHAPE trial comparing simple versus radical hysterectomy. J Clin Oncol. 2025;43:167-79.
13. Carter J, Huang HQ, Monk BJ, et al. Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278). Gynecol Oncol. 2025;195:50-8.
14. Lécuru F, Mathevet P, Querleu D, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29:1686-91.
15. Sponholtz SE, Mogensen O, Hildebrandt MG, et al. Sentinel lymph node mapping in early-stage cervical cancer - a national prospective multicenter study (SENTIREC trial). Gynecol Oncol. 2021;162:546-54.
16. Mathevet P, Lécuru F, Uzan C, et al.; Senticol 2 group. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021;148:307-15.
17. Cibula D, Kocian R, Plaikner A, et al. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: the SENTIX trial. Eur J Cancer. 2020;137:69-80.
18. Miller KM, Liu C, Zhou Q, et al. RELEVANT-C study: patient-reported prevalence of lower extremity lymphedema after sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage cervical cancer. Int J Gynecol Cancer. 2025;35:100063.
19. Hu TWY, Huang Y, Li N, Nie D, Li Z. Comparison of laparoscopic versus open radical hysterectomy in patients with early-stage cervical cancer: a multicenter study in China. Int J Gynecol Cancer. 2020;30:1143-50.
20. Guo C, Tang X, Meng Y, et al. Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: a real-world multicenter study of a large Chinese cohort from 2006 to 2017. Cancer Med. 2020;9:5908-21.
21. Li X, Pei X, Li H, et al. Comparative single-center study between modified laparoscopic radical hysterectomy and open radical hysterectomy for early-stage cervical cancer. World J Surg Oncol. 2022;20:392.
22. Li Y, Zhao J, Ding X, et al. Oncologic outcomes of laparoscopic radical hysterectomy incorporating modified tumor-free techniques. Obstet Gynecol. 2025;145:134-43.
23. Zhao D, Li B, Wang Y, Liu S, Zhang Y, Yuan G. Clinical outcomes in early cervical cancer patients treated with nerve plane-sparing laparoscopic radical hysterectomy. J Minim Invasive Gynecol. 2020;27:687-96.
24. Pei K, Li D, Xi M. Simple Hysterectomy as a viable alternative to radical hysterectomy for early-stage cervical cancer: a population-based cohort study. Ann Surg Oncol. ;2025:9058-69.
25. Fu J, Li P, Yao J, et al. The potential for de-escalation radical surgery in women with stage IB2 cervical cancer (FIGO 2018): a multi-institutional experience of 63,926 cases over a 14-year period in China. BMC Surg. 2025;25:187.
26. Sun H, Cao D, Shen K, et al. Piver type II vs. type III hysterectomy in the treatment of early-stage cervical cancer: midterm follow-up results of a randomized controlled trial. Front Oncol. 2018;8:568.
27. Chen L, Zhang WN, Zhang SM, Gao Y, Zhang TH, Zhang P. Class I hysterectomy in stage Ia2-Ib1 cervical cancer. Wideochir Inne Tech Maloinwazyjne. 2018;13:494-500.
28. Liu Q, Xu Y, He Y, et al. Simple hysterectomy for patients with stage IA2 cervical cancer: a retrospective cohort study. Cancer Manag Res. 2021;13:7823-32.
29. Tu H, Huang H, Li Y, et al. Sentinel-lymph-node biopsy alone or with lymphadenectomy in cervical cancer. N Engl J Med. 2025;393:1463-74.
30. Wang K, Zhai Q, Xie Y, et al. Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer. Int J Gynecol Cancer. 2026;36:102881.
31. Yuan SH, Xiong Y, Wei M, et al. Sentinel lymph node detection using methylene blue in patients with early stage cervical cancer. Gynecol Oncol. 2007;106:147-52.
32. Du XL, Sheng XG, Jiang T, et al. Sentinel lymph node biopsy as guidance for radical trachelectomy in young patients with early stage cervical cancer. BMC Cancer. 2011;11:157.
33. Wei R, Jiang G, Lv M, et al. TMTP1-modified indocyanine green-loaded polymeric micelles for targeted imaging of cervical cancer and metastasis sentinel lymph node in vivo. Theranostics. 2019;9:7325-44.
34. Wang Y, Dan Z, Yuan G, et al. Detection of sentinel lymph node in laparoscopic surgery for uterine cervical cancer using carbon nanoparticles. J Surg Oncol. 2020;122:934-40.
35. Ya X, Qian W, Huiqing L, et al. Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer: a prospective study. BJOG. 2021;128:890-8.
36. Tu H, Wan T, Zhang X, et al. Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study. World J Surg Oncol. 2020;18:133.
37. Sun W, Chen X, Fu S, Huang X. Feasibility of sentinel lymph node mapping with carbon nanoparticles in cervical cancer: a retrospective study. Cancer Control. 2023;30:10732748231195716.
38. Leitao MM Jr, Bixel KL, Chase DM, et al. ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer. Int J Gynecol Cancer. 2025;35:101760.
39. Falconer H, Palsdottir K, Stalberg K, et al. Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. Int J Gynecol Cancer. 2019;29:1072-6.
40. Chao X, Wu M, Ma S, et al. Efficacy of different surgical approaches on survival outcomes in patients with early-stage cervical cancer: protocol for a multicentre longitudinal study in China. BMJ Open. 2020;10:e038020.
